State Medicaid programs for low-income families are the single biggest source of coverage, giving 31.6 million people access ...

Patients who would benefit from a GLP-1 face significant challenges when it comes to access. Shortages have made it difficult ...

We have hardly begun to understand how inextricably our own health and safety are intertwined with those of our wild ...

The makers of Ozempic and Zepbound are fighting to stop compounded copies of their drugs. But it’s unclear whether they can ...

Not only is Wegovy extremely effective (people lose about 15% of their body weight in a year), it also appears to have many ...

Robert F. Kennedy Jr. has pledged to tackle high rates of chronic diseases such as diabetes and obesity as President-elect ...

Go on, give it a shot. Ozempic and other game-changing weight loss drugs are popular for a reason — but, nutrition experts ...

Ozempic, a Type 2 diabetes medication that has gained widespread attention, is known for its appetite-suppressing properties.

SGLT2 inhibitors may help reduce the risk of nephrolithiasis in patients with type 2 diabetes, including those with co-existing gout. Recent large-scale studies support that sodium-glucose ...

The best online providers offer strong support services to help you succeed in your GLP-1 weight loss journey.

GLP-1 drug shortages, driven by cosmetic and weight loss purposes, result in access disparities among individuals with ...